Today on
The information in the press release is intended for investors.
Adoption of income statements and balance sheets for 2024 and discharge from liability
The AGM resolved to adopt the income statements and balance sheets for the company and the group for the financial year 2023. The members of the board of directors and the CEO were discharged from liability for the financial year 2023.
Allocation of earnings
The AGM resolved that no dividend shall be paid for 2023 and that the company’s unappropriated earnings shall be carried forward.
Election of board members and auditors, and fees to the board of directors and auditors
The AGM resolved that the number of members of the board of directors shall be five ordinary members without deputies and that the number of auditors shall be one registered accounting firm.
The AGM re-elected Jan-Eric Österlund,
The registered accounting firm
The AGM resolved that fees to the chairman of the board of directors shall be paid with
The AGM resolved that members of the board of directors (in addition to remuneration for expenses relating to travel and accommodation) domiciled in
The AGM resolved that remuneration, for services rendered by the auditor of the company, shall be paid in accordance with approved invoice.
Approval of principles for the appointment of the nomination committee
The AGM resolved, in accordance with the nomination committee’s proposal, to approve the adjusted principles for the appointment of the nomination committee.
Approval of the board of directors’ remuneration report
The AGM resolved to approve the remuneration report for the financial year 2023.
For more information, please contact
Jan-Eric Österlund, Chairman of the Board
E-mail: jan-eric@osterlund.co.uk
Phone: +44 7785 368 155
E-mail: petter.s.lindqvist@isofolmedical.com
Phone: +46 (0) 739 60 12 56
The information was submitted for publication, through the agency of the contact persons set out above, at
About
www.isofolmedical.com
© Modular Finance, source